Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-03

Clinical Trial Update: Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating inhaled nitric oxide for microvascular dysfunction in traumatic brain injury. Recruitment is currently enrolling by invitation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: University of Pennsylvania | Conditions: Traumatic Brain Injury | Phase 2 | Status: ENROLLING_BY_INVITATION